Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| C6-Bis-phosphoramidic acid diethyl ester | C14H34N2O6P2 | 1446282-35-4 | Details |
| Carboxyfluorescein-PEG12-NHS | 2246595-66-2 | Details |
| Cbz-NH-PEG1-CH2COOH | C12H15NO5 | 1260092-43-0 | Details |
| Cbz-NH-PEG1-CH2CH2COOH | C13H17NO5 | 1205751-19-4 | Details |
| Cbz-aminooxy-PEG8-acid | C27H45NO13 | 2353410-09-8 | Details |
| Ro 48-8071 fumarate | C23H27BrFNO2.C4H4O4 | 189197-69-1 | Details |
| MDK83190；Apoptosis Activator 2 | C15H9Cl2NO2 | 79183-19-0 | Details |
| Cbz-NH-PEG3-CH2COOH | C7H15NO4 | 462100-05-6 | Details |
| Cbz-NH-PEG5-CH2COOH | C20H31NO9 | 1449390-66-2 | Details |
| CCK2R Ligand-Linker Conjugates 1 | C72H110N12O27S | 1452145-13-9 | Details |
| Cbz-NH-PEG2-CH2COOH | C14H19NO6 | 165454-06-8 | Details |
| Cbz-NH-PEG12-C2-acid | C35H61NO16 | 1334177-88-6 | Details |
| Cbz-Phe-(Alloc)Lys-PAB-PNP | C41H43N5O11 | 159857-90-6 | Details |
| Cl-C6-PEG4-C3-COOH | C18H35ClO6 | 2127391-58-4 | Details |
| CL2A-SN-38 | C73H97N11O22 | 1279680-68-0 | Details |
| Plerixafor；AMD 3100;AMD-3329;JM3100 | C28H54N8 | 110078-46-1 | Details |
| CL2 Linker | C68H103N11O22 | 2270986-66-6 | Details |
| CL2A | C51H79N9O18 | 1846605-04-6 | Details |
| ATRA-hydroxyimino；CRABP-II ligand 1 | C20H27NO3 | 135325-47-2 | Details |
| Afatinib Dimaleate；Afatinib (BIBW2992) Dimaleate;BIBW2992;BIBW 2992MA2;Afatinib | C28H29ClFN5O7 | 850140-73-7 | Details |
| DBCO-C-PEG1 | C22H22N2O3 | 2377004-09-4 | Details |
| DBCO-Biotin | C28H30N4O3S | 1418217-95-4 | Details |
| Nintedanib；BIBF 1120;Intedanib | C31H33N5O4 | 656247-17-5 | Details |
| GSK503 | C31H38N6O2 | 1346572-63-1 | Details |
| Cyclooctyne-O-PFP ester | C16H13F5O3 | 886209-60-5 | Details |
| DBCO-NH-(CH2)4COOH | C24H24N2O4 | 2375193-74-9 | Details |
| Intepirdine；RVT-101;GSK-742457;SB 742457 | C19H19N3O2S | 607742-69-8 | Details |
| DBCO-CONH-S-S-NHS ester | C28H27N3O6S2 | 1435934-53-4 | Details |
| Plerixafor octahydrochloride；SID791 octahydrochloride;Plerixafor 8HCl (AMD3100 8HCl);JM 3100 8HCl;JM3100 octahydrochloride;Plerixafor 8HCl;AMD 3100 octahydrochloride | C28H54N8 | 155148-31-5 | Details |
| DBCO-NH-Boc | C23H24N2O3 | 1539290-74-8 | Details |
| Canagliflozin；JNJ 28431754AAA;TA 7284;JNJ 28431754;JNJ 24831754ZAE | C24H25FO5S | 842133-18-0 | Details |
| DBCO-PEG4-triethoxysilane | C39H57N3O10Si | 2353410-02-1 | Details |
| DBCO-PEG4-VC-PAB-DMEA-PNU-159682 | C86H106N10O26 | 2259318-56-2 | Details |
| DBCO-PEG1-amine | C23H25N3O3 | 2364591-79-5 | Details |
| DBCO-PEG9-DBCO | C58H70N4O13 | 2353409-50-2 | Details |
| Thalidomide-O-amido-C8-NH2；E3 Ligase Ligand-Linker Conjugates 20;Cereblon Ligand-Linker Conjugates 2 | C23H30N4O6 | 1950635-15-0 | Details |
| DBCO-PEG1-acid | C24H24N2O5 | 2228857-38-1 | Details |
| DM4-SMCC | C54H72ClN5O16S | 1228105-52-9 | Details |
| DBCO-PEG6-amine | C33H45N3O8 | 2353409-98-8 | Details |
| LXR-623；WAY 252623;LXR623 | C21H12ClF5N2 | 875787-07-8 | Details |
| Diethylene glycol bis(p-toluenesulfonate)；Bis-Tos-PEG2;Diethylene glycol di(p-toluenesulfonate) | C18H22O7S2 | 7460-82-4 | Details |
| DBCO-PEG2-NH-Boc | C30H37N3O6 | 2377004-08-3 | Details |
| Di(N-succinimidyl)adipate | C14H16N2O8 | 59156-70-6 | Details |
| DBCO-PEG1-NH-Boc | C28H33N3O5 | 2364591-77-3 | Details |
| Dde Biotin-PEG4-TAMRA-PEG4 Alkyne | C72H100N9O18S+ | 2353409-55-7 | Details |
| DBCO-PEG1-NHS ester | C28H27N3O7 | 2228857-34-7 | Details |
| DBCO-NHS ester 3 | C24H20N2O5 | 1393350-27-0 | Details |
| DBCO-PEG2-amine | C25H29N3O4 | 2250216-96-5 | Details |
| AT7519 Hydrochloride；AT7519 HCl;AT 7519 hydrochloride salt | C16H18Cl3N5O2 | 902135-91-5 | Details |
| DBCO-PEG4-Desthiobiotin | C39H53N5O8 | 2032788-37-5 | Details |
| DBCO-PEG4-NH-Boc | C34H45N3O8 | 2353410-17-8 | Details |
| DBCO-PEG5-DBCO | C50H54N4O9 | 2363130-04-3 | Details |
| DBCO-PEG1 | C21H20N2O3 | 1839049-33-0 | Details |
| Diketone-PEG4-Biotin | C33H50N4O9S | 2353409-85-3 | Details |
| GW9508；GW 9508 | C22H21NO3 | 885101-89-3 | Details |
| DBCO-PEG9-amine | C39H57N3O11 | 2353409-99-9 | Details |
| Parecoxib；Valus-P;Vorth-P;SC 69124 | C19H18N2O4S | 198470-84-7 | Details |
| DBCO-PEG4-alcohol | C29H36N2O6 | 1416711-60-8 | Details |
| Thalidomide-O-amido-C4-NH2；Cereblon Ligand-Linker Conjugates 6;E3 Ligase Ligand-Linker Conjugates 19 | C19H22N4O6 | 1799711-24-2 | Details |
| DBCO-(PEG2-VC-PAB-MMAE)2 | C149H224N22O32 | 2259318-55-1 | Details |
| DBCO-PEG2-acid | C26H28N2O6 | 2304558-25-4 | Details |
| Diketone-PEG4-PFP ester | C30H34F5NO9 | 2353409-84-2 | Details |
| DOTA-?NHS-?ester | C20H31N5O10 | 170908-81-3 | Details |
| DSPE-PEG5-propargyl | C55H104NO14P | 2112737-93-4 | Details |
| E3 ligase Ligand 9 | C21H32N2O6 | 87304-15-2 | Details |
| VH032-cyclopropane-F；Phenolic VH101;VHL ligand 3;E3 ligase Ligand 19 | C26H33FN4O5S | 2306193-99-5 | Details |
| (S,R,S)-AHPC-C10-NH2；VH032-C10-NH2 | C33H51N5O4S | 2341796-74-3 | Details |
| cIAP1 Ligand-Linker Conjugates 12；E3 ligase Ligand-Linker Conjugates 38 | C46H64N4O12S2 | 2095244-52-1 | Details |
| DSPE-PEG4-DBCO | C71H116N3O15P | 2112738-14-2 | Details |
| E3 ligase Ligand 8 | C31H34N2O6 | 1225383-33-4 | Details |
| Nutlin carboxylic acid；MDM2 ligand 1;E3 ligase Ligand 16 | C32H32Cl2N4O6 | 2249750-27-2 | Details |
| E3 ligase Ligand 14 | C38H52N4O7 | 2241489-43-8 | Details |
| cIAP1 Ligand-Linker Conjugates 15；E3 ligase Ligand-Linker Conjugates 34 | C37H47N3O8 | 1225433-96-4 | Details |
| E3 ligase Ligand 10 | C47H52N4O7 | 1073560-68-5 | Details |
| Daclatasvir dihydrochloride；BMS-790052 dihydrochloride | C40H51ClN8O6 | 1009119-65-6 | Details |
| DSPE-PEG8-Mal | C64H119N2O19P | 2112737-94-5 | Details |
| DM4-SPDP | C45H61ClN4O14S2 | 2245698-48-8 | Details |
| DNP-PEG4-DBCO | C35H39N5O10 | 2149585-17-9 | Details |
| DMAC-SPP | C17H21N3O5S2 | 663599-10-8 | Details |
| cIAP1 Ligand-Linker Conjugates 5；E3 ligase Ligand-Linker Conjugates 39 | C37H55N5O8S | 2113688-20-1 | Details |
| E3 ligase Ligand 18 | C17H17ClN6O4S | 2241669-88-3 | Details |
| cIAP1 Ligand-Linker Conjugates 14；E3 ligase Ligand-Linker Conjugates 36 | C39H49N3O10 | 1351169-40-8 | Details |
| Levobupivacaine | C18H28N2O | 27262-47-1 | Details |
| Pomalidomide-C2-NH2；Cereblon Ligand-Linker Conjugates 15;4-[(2-Aminoethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | C15H16N4O4 | 1957235-66-3 | Details |
| Pomalidomide-PEG3-C2-NH2；E3 ligase Ligand-Linker Conjugates 30;Cereblon Ligand-Linker Conjugates 5 | C21H28N4O7 | 2093416-31-8 | Details |
| DMAC-PDB | C12H16N2O3S2 | 663599-04-0 | Details |
| cIAP1 ligand 2；E3 ligase Ligand 11 | C34H40N4O6S | 2357114-70-4 | Details |
| cIAP1 Ligand-Linker Conjugates 11；E3 ligase Ligand-Linker Conjugates 33 | C35H43N3O7 | 1239943-19-1 | Details |
| cIAP1 Ligand-Linker Conjugates 1；E3 ligase Ligand-Linker Conjugates 41 | C42H57N5O9S | 2357114-75-9 | Details |
| DSPE-PEG5-azide | C54H105N4O14P | 2112737-73-0 | Details |
| cIAP1 Ligand-Linker Conjugates 11 Hydrochloride；E3 ligase Ligand-Linker Conjugates 33 Hydrochloride | C35H44ClN3O7 | 1239866-59-1 | Details |
| cIAP1 Ligand-Linker Conjugates 2；E3 ligase Ligand-Linker Conjugates 37 | C37H48N4O7 | 1312302-14-9 | Details |
| Tazemetostat；EPZ6438;E-7438 | C34H44N4O4 | 1403254-99-8 | Details |
| DSPE-PEG4-acid | C52H100NO15P | 2112738-58-4 | Details |
| cIAP1 Ligand-Linker Conjugates 3；E3 ligase Ligand-Linker Conjugates 40 | C39 H56 N4 O11 S | 2222354-20-1 | Details |
| cIAP1 ligand 1；E3 ligase Ligand 12 | C31H42N4O6S | 2095244-42-9 | Details |
| cIAP1 Ligand-Linker Conjugates 15 hydrochloride；E3 ligase Ligand-Linker Conjugates 34 hydrochloride | C37H48ClN3O8 | 1225383-36-7 | Details |
| Obeticholic Acid；INT-747;6-ECDCA;6-Ethylchenodeoxycholic acid | C26H44O4 | 459789-99-2 | Details |
| Everolimus；SDZ-RAD;RAD001 | C53H83NO14 | 159351-69-6 | Details |
| (4R,5S)-nutlin carboxylic acid；MDM2 ligand 2;E3 ligase Ligand 15 | C32 H32 Cl2 N4 O6 | 2306390-08-7 | Details |
| Product Total： Product Page： | ||||
| 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 | ||||